Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/18/2025

Management of Completely Resected Malignant Phyllodes Tumor

Immediate Post-Resection Assessment

  • The British Journal of Cancer recommends that for a large (>13 cm) completely resected malignant phyllodes tumor, adjuvant radiotherapy to the chest wall should be strongly considered to improve local control, as the tumor size far exceeds the 5 cm threshold where radiotherapy has demonstrated benefit 1, 2
  • Confirm that surgical margins are truly negative and ideally ≥1 cm, as margin status is the single most important factor for preventing local recurrence, according to Praxis Medical Insights 3, 4
  • If margins are close (<5 mm) or positive, re-excision should be attempted if feasible, as recommended by the British Journal of Cancer 1, 2

Adjuvant Radiotherapy Decision

  • The British Journal of Cancer recommends adjuvant radiotherapy for tumor sizes >5 cm, as it has been demonstrated to improve local control specifically in malignant phyllodes tumors 1, 2
  • The National Comprehensive Cancer Network is not mentioned, however the British Journal of Cancer states that radiotherapy improves local control but not overall survival 1, 2

What NOT to Do

  • The British Journal of Cancer recommends that axillary staging is not required, as phyllodes tumors rarely metastasize to lymph nodes (<1% have positive nodes) 1, 2, 3, 4
  • Praxis Medical Insights states that adjuvant chemotherapy has no proven role in reducing recurrence or death, and should not be used 3, 4, 5

Reconstruction Timing

  • The British Journal of Cancer recommends that reconstruction should be delayed until after completion of radiotherapy and when local recurrence risk has diminished (typically 2 years post-treatment) 1, 2

Surveillance Strategy

  • Praxis Medical Insights recommends monitoring for local recurrence, which is the primary concern, and watching for distant metastases, most commonly to the lungs 3, 4, 5
  • The 5-year disease-free survival for malignant phyllodes tumors is 66.1%, according to Praxis Medical Insights 3, 4

Management of Recurrence

  • Praxis Medical Insights recommends that local recurrence should be treated with re-excision with wide tumor-free margins, and distant metastases should be prioritized with surgical resection or local ablative therapy when feasible 3, 4, 5

Critical Pitfalls to Avoid

  • The British Journal of Cancer recommends that phyllodes tumors should not be treated as epithelial breast cancer, and require sarcoma-directed management principles 1, 2, 5
  • The British Journal of Cancer states that radiotherapy should not be skipped, as it is strongly supported for local control in large and malignant tumors 1, 2

REFERENCES

3

Diagnostic Criteria and Treatment of Phyllodes Tumors [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Malignant Phyllodes Tumors [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Treatment Regimens for Metastatic Malignant Phyllodes Tumor [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025